Your daily adult tube feed all in one place!
African babies are set to receive a £3 malaria vaccine that could potentially eradicate the disease within a decade.
The first doses of the R21 jab, developed by a team at the University of Oxford, will be given to babies under the age of two in the Ivory Coast today and South Sudan tomorrow (Tuesday).
It marks the culmination of 30 years of research into a vaccine against malaria, which kills more than 600,000 people a year - most of them in Africa and 80 per cent under the age of five.
The Serum Institute, who manufacture the vaccine, have already made 25 million doses and has the capacity to increase production to 100 million a year.
The only other malaria vaccine, a jab called RTS,S, was introduced earlier this year but is twice as expensive and limited by manufacturing constraints.
African babies will receive a £3 malaria vaccine that could eradicate malaria within a decade
The first doses of the R21 jab, developed by a team at the University of Oxford, will be given to babies under the age of two in the Ivory Coast today and South Sudan tomorrow (Tuesday)
'A malaria-free world is finally in sight,' Adar Poonawalle, chief executive of the Serum Institute in India, told the Sunday Times.
'Cost is absolutely the key question. If this was a $10 (£7.90) vaccine, just forget it - you wouldn't be able to reach the kind of countries we have because the budgets just wouldn't allow it.'
Fifteen countries in Africa including the Central African Republic, Democratic Republic of Congo, Chad, Ghana, Mozambique, Uganda, Burkina Faso, Burundi and Nigeria are expected to introduce the vaccine by the end of the year.
Another 15 nations are due to follow.
The new vaccine - funded by Gavi, a global vaccination alliance of charities, the World Health Organisation and governments including the UK's - is approved for children up to the age of three.
Sir Adrian Hill, director of the Jenner Institute at Oxford, was involved in developing both the Astra-Zeneca Covid vaccine and the new malaria jab.
He said: 'I've been doing work on malaria vaccines since 1994. It's been long awaited, but here we finally are.
'For the first time, really in the last couple of years, eradication is beginning to look really credible.
The malaria vaccine arrives in South Sudan, as 15 countries across Africa including the Central African Republic, Democratic Republic of Congo, Chad, Ghana, Mozambique, Uganda, Burkina Faso, Burundi and Nigeria are expected to introduce it by the end of the year
'I think the whole thing is doable, not in the next five years, but maybe in the next 10.'
In trials, the vaccine has been shown to be up to 79 per cent effective at preventing the most deadly strain of malaria - and the most common in Africa - in young children.
It works by targeting the parasite that causes the disease.
Trials to see if it is effective for pregnant women are expected to begin in the coming weeks.